Uveal melanoma incidence trends in Canada: a national comprehensive population-based study.


Journal

The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041

Informations de publication

Date de publication:
12 2019
Historique:
received: 01 08 2018
revised: 19 11 2018
accepted: 12 01 2019
pubmed: 2 3 2019
medline: 30 5 2020
entrez: 2 3 2019
Statut: ppublish

Résumé

In the developed countries, uveal melanoma is the most common primary intraocular malignancy in adults. Little is known about the epidemiological and geographical distribution of uveal melanoma in Canada. To determine the incidence patterns and geographical distribution of uveal melanoma cases in Canada, we conducted the first comprehensive, population-based national study of this malignancy across all Canadian provinces and territories during 1992-2010 years. We examined two independent population-based registries: the Canadian Cancer Registry and Le Registre Québécois du Cancer using corresponding International Classification of Diseases for Oncology-3rd edition codes for all histological subtypes of uveal melanoma. We report that 2215 patients were diagnosed with uveal melanoma, of which 52.1% were males. The average -annual incidence rate of uveal melanoma in Canada was 3.75 cases per million individuals per year (95% CI 3.60 to 3.91). Overall, we report a steady increase in uveal melanoma incidence with an annual increase of 0.074 cases per million individuals per year. Significant differences in the incidence rates of uveal melanoma between Canadian provinces and territories were noted, where the highest crude incidence was in British Columbia and Saskatchewan with rates of 6.38 and 5.47 cases per million individuals per year, respectively. This work, for the first time, defines the disease burden of uveal melanoma in Canada and highlights important longitudinal, geographical and spatial differences in the distribution of uveal melanoma in Canada.

Sections du résumé

BACKGROUND
In the developed countries, uveal melanoma is the most common primary intraocular malignancy in adults. Little is known about the epidemiological and geographical distribution of uveal melanoma in Canada.
METHODS
To determine the incidence patterns and geographical distribution of uveal melanoma cases in Canada, we conducted the first comprehensive, population-based national study of this malignancy across all Canadian provinces and territories during 1992-2010 years. We examined two independent population-based registries: the Canadian Cancer Registry and Le Registre Québécois du Cancer using corresponding International Classification of Diseases for Oncology-3rd edition codes for all histological subtypes of uveal melanoma.
RESULTS
We report that 2215 patients were diagnosed with uveal melanoma, of which 52.1% were males. The average -annual incidence rate of uveal melanoma in Canada was 3.75 cases per million individuals per year (95% CI 3.60 to 3.91). Overall, we report a steady increase in uveal melanoma incidence with an annual increase of 0.074 cases per million individuals per year. Significant differences in the incidence rates of uveal melanoma between Canadian provinces and territories were noted, where the highest crude incidence was in British Columbia and Saskatchewan with rates of 6.38 and 5.47 cases per million individuals per year, respectively.
CONCLUSIONS
This work, for the first time, defines the disease burden of uveal melanoma in Canada and highlights important longitudinal, geographical and spatial differences in the distribution of uveal melanoma in Canada.

Identifiants

pubmed: 30819691
pii: bjophthalmol-2018-312966
doi: 10.1136/bjophthalmol-2018-312966
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1872-1876

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Feras M Ghazawi (FM)

Division of Dermatology, University of Ottawa, Ottawa, Ontario, Canada.

Rami Darwich (R)

Faculty of Medicine, McGill University Health Centre, Montreal, Québec, Canada.

Michelle Le (M)

Division of Dermatology, McGill University Health Centre, Montreal, Québec, Canada.

Elham Rahme (E)

Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Québec, Canada.

Andrei Zubarev (A)

Division of Dermatology, McGill University Health Centre, Montreal, Québec, Canada.

Linda Moreau (L)

Division of Dermatology, McGill University Health Centre, Montreal, Québec, Canada.

Julia Valdemarin Burnier (JV)

Department of Ophthalmology, McGill University Health Centre, Montreal, Québec, Canada.

Denis Sasseville (D)

Division of Dermatology, McGill University Health Centre, Montreal, Québec, Canada.

Miguel N Burnier (MN)

The Henry C Witelson Ocular Pathology Laboratory, McGill University, Montreal, Québec, Canada.

Ivan V Litvinov (IV)

Division of Dermatology, McGill University Health Centre, Montreal, Québec, Canada ivan.litvinov@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH